Task A53: High Throughput Evaluation of COVID-19 Therapeutics in Small Animal Models
$417,584N01FY2021AINIH
Utah State University, Logan UT
Investigators
Abstract
This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.
View original record on NIH RePORTER →